These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9797251)
1. Bactericidal activities of the pyrrole derivative BM212 against multidrug-resistant and intramacrophagic Mycobacterium tuberculosis strains. Deidda D; Lampis G; Fioravanti R; Biava M; Porretta GC; Zanetti S; Pompei R Antimicrob Agents Chemother; 1998 Nov; 42(11):3035-7. PubMed ID: 9797251 [TBL] [Abstract][Full Text] [Related]
2. Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity. Wavhale RD; Martis EAF; Ambre PK; Wan B; Franzblau SG; Iyer KR; Raikuvar K; Macegoniuk K; Berlicki Ł; Nandan SR; Coutinho EC Bioorg Med Chem; 2017 Sep; 25(17):4835-4844. PubMed ID: 28778369 [TBL] [Abstract][Full Text] [Related]
3. MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212. La Rosa V; Poce G; Canseco JO; Buroni S; Pasca MR; Biava M; Raju RM; Porretta GC; Alfonso S; Battilocchio C; Javid B; Sorrentino F; Ioerger TR; Sacchettini JC; Manetti F; Botta M; De Logu A; Rubin EJ; De Rossi E Antimicrob Agents Chemother; 2012 Jan; 56(1):324-31. PubMed ID: 22024828 [TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity. Biava M; Porretta GC; Poce G; Supino S; Deidda D; Pompei R; Molicotti P; Manetti F; Botta M J Med Chem; 2006 Aug; 49(16):4946-52. PubMed ID: 16884306 [TBL] [Abstract][Full Text] [Related]
5. Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N'-((E)-3,7-dimethylocta-2,6-dienyl)ethane-1,2-diamine (SQ109) Pyrrole Hybrid Derivatives: Discovery of Potent Antitubercular Agents Effective against Multidrug-Resistant Mycobacteria. Bhakta S; Scalacci N; Maitra A; Brown AK; Dasugari S; Evangelopoulos D; McHugh TD; Mortazavi PN; Twist A; Petricci E; Manetti F; Castagnolo D J Med Chem; 2016 Mar; 59(6):2780-93. PubMed ID: 26907951 [TBL] [Abstract][Full Text] [Related]
6. New pyrrole derivatives as antimycobacterial agents analogs of BM212. Biava M; Fioravanti R; Porretta GC; Deidda D; Maullu C; Pompei R Bioorg Med Chem Lett; 1999 Oct; 9(20):2983-8. PubMed ID: 10571160 [TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial compounds. New pyrrole derivatives of BM212. Biava M; Porretta GC; Deidda D; Pompei R; Tafi A; Manetti F Bioorg Med Chem; 2004 Mar; 12(6):1453-8. PubMed ID: 15018918 [TBL] [Abstract][Full Text] [Related]
8. BM 212 and its derivatives as a new class of antimycobacterial active agents. Biava M Curr Med Chem; 2002 Nov; 9(21):1859-69. PubMed ID: 12369872 [TBL] [Abstract][Full Text] [Related]
9. New derivatives of BM212: A class of antimycobacterial compounds based on the pyrrole ring as a scaffold. Biava M; Porretta GC; Manetti F Mini Rev Med Chem; 2007 Jan; 7(1):65-78. PubMed ID: 17266639 [TBL] [Abstract][Full Text] [Related]
10. 1,5-Diphenylpyrrole derivatives as antimycobacterial agents. Probing the influence on antimycobacterial activity of lipophilic substituents at the phenyl rings. Biava M; Porretta GC; Poce G; De Logu A; Saddi M; Meleddu R; Manetti F; De Rossi E; Botta M J Med Chem; 2008 Jun; 51(12):3644-8. PubMed ID: 18494459 [TBL] [Abstract][Full Text] [Related]
11. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis. Li W; Upadhyay A; Fontes FL; North EJ; Wang Y; Crans DC; Grzegorzewicz AE; Jones V; Franzblau SG; Lee RE; Crick DC; Jackson M Antimicrob Agents Chemother; 2014 Nov; 58(11):6413-23. PubMed ID: 25136022 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Rastogi N; Labrousse V; Goh KS Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093 [TBL] [Abstract][Full Text] [Related]
13. Tapping into the antitubercular potential of 2,5-dimethylpyrroles: A structure-activity relationship interrogation. Semenya D; Touitou M; Masci D; Ribeiro CM; Pavan FR; Dos Santos Fernandes GF; Gianibbi B; Manetti F; Castagnolo D Eur J Med Chem; 2022 Jul; 237():114404. PubMed ID: 35486992 [TBL] [Abstract][Full Text] [Related]
14. Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212. Biava M; Cesare Porretta G; Deidda D; Pompei R; Tafi A; Manetti F Bioorg Med Chem; 2003 Feb; 11(4):515-20. PubMed ID: 12538016 [TBL] [Abstract][Full Text] [Related]
15. Ruiz P; Causse M; Vaquero M; Casal M Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670412 [TBL] [Abstract][Full Text] [Related]
17. Pyrrolnitrin and related pyrroles endowed with antibacterial activities against Mycobacterium tuberculosis. Di Santo R; Costi R; Artico M; Massa S; Lampis G; Deidda D; Pompei R Bioorg Med Chem Lett; 1998 Oct; 8(20):2931-6. PubMed ID: 9873650 [TBL] [Abstract][Full Text] [Related]
18. In-vitro and intracellular activity of rifabutin on drug-susceptible and multiple drug-resistant (MDR) tubercle bacilli. Luna-Herrera J; Reddy MV; Gangadharam PR J Antimicrob Chemother; 1995 Aug; 36(2):355-63. PubMed ID: 8522465 [TBL] [Abstract][Full Text] [Related]
19. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis. Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616 [TBL] [Abstract][Full Text] [Related]
20. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria. Ho YI; Chan CY; Cheng AF J Antimicrob Chemother; 1997 Jul; 40(1):27-32. PubMed ID: 9249201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]